Related Experiment Video
Updated: Mar 29, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Who and when should we screen for prostate cancer? Interviews with key opinion leaders
Sigrid Carlsson1, Michael Leapman2, Peter Carroll3
1Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, 485 Lexington Avenue, New York, 10017, NY, USA. carlssos@mskcc.org
Abstract:
Prostate cancer screening using prostate-specific antigen (PSA) is highly controversial. In this Q & A, Guest Editors for BMC Medicine's 'Spotlight on Prostate Cancer' article collection, Sigrid Carlsson and Andrew Vickers, invite some of the world's key opinion leaders to discuss who, and when, to screen for prostate cancer. In response to the points of view from the invited experts, the Guest Editors summarize the experts' views and give their own personal opinions on PSA screening.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
05:49Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
Related Concept Videos
Cancer Prevention
Cancer Prevention
Some...